IMC Chicago’s Zimmer Biomet ZBH Stock Holding History

IMC Chicago’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.18M	Sell	24,100 -4,200	-15%	-$385K	﹤0.01%	2485
2025 Q4	$2.54M	Sell	28,300 -3,000	-10%	-$284K	﹤0.01%	2227
2025 Q3	$3.08M	Sell	31,300 -4,200	-12%	-$416K	﹤0.01%	1945
2025 Q2	$3.24M	Buy	+35,500	New	+$3.43M	﹤0.01%	1686
2025 Q1	–	Sell	-26,000	Closed	-$2.75M	–	3545
2024 Q4	$2.75M	Buy	26,000 +10,800	+71%	+$1.16M	﹤0.01%	1633
2024 Q3	$1.64M	Buy	15,200 +3,000	+25%	+$327K	﹤0.01%	1786
2024 Q2	$1.32M	Buy	+12,200	New	+$1.44M	﹤0.01%	1799

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's ZBH Position: Q1 2026 in Review

IMC Chicago opened a new position in Zimmer Biomet (ZBH) in Q1 2026: 6,114 shares worth $553K. The stake represents ﹤0.01% of the portfolio and ranks #3937 among its holdings.

912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

IMC Chicago held 6,114 shares of Zimmer Biomet worth $553K as of Q1 2026.
Zimmer Biomet was a new IMC Chicago position in Q1 2026.
Zimmer Biomet made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3937 holding.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.